BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35643493)

  • 1. Albumin/fibrinogen ratio, a predictor of chemotherapy resistance and prognostic factor for advanced gastric cancer patients following radical gastrectomy.
    Zhao G
    BMC Surg; 2022 May; 22(1):207. PubMed ID: 35643493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative albumin-to-fibrinogen ratio predicts severe postoperative complications in elderly gastric cancer subjects after radical laparoscopic gastrectomy.
    You X; Zhou Q; Song J; Gan L; Chen J; Shen H
    BMC Cancer; 2019 Sep; 19(1):931. PubMed ID: 31533682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinum-based chemotherapy.
    Ying J; Zhou D; Gu T; Huang J; Liu H
    BMC Cancer; 2019 Mar; 19(1):288. PubMed ID: 30925910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic Value of Pre-treatment Albumin/Fibrinogen Ratio in Patients with Diffuse Large B-cell Lymphoma].
    Deng H; Zhang L; Wang HY; Huang MJ; Wei J; Zou XL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):762-768. PubMed ID: 37356937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative albumin-to-fibrinogen ratio predicts chemotherapy resistance and prognosis in patients with advanced epithelial ovarian cancer.
    Yu W; Ye Z; Fang X; Jiang X; Jiang Y
    J Ovarian Res; 2019 Sep; 12(1):88. PubMed ID: 31533857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of pretreatment albumin-to-fibrinogen ratio in small cell lung cancer patients receiving first-line platinum-based chemotherapy.
    Li Q; Li L; Wang Y; Xu C; Zou J
    Heliyon; 2023 Sep; 9(9):e19225. PubMed ID: 37662747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
    Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
    [No Abstract]   [Full Text] [Related]  

  • 8. Pretreatment Albumin-to-Fibrinogen Ratio Independently Predicts Chemotherapy Response and Prognosis in Patients with Locally Advanced Rectal Cancer Undergoing Total Mesorectal Excision After Neoadjuvant Chemoradiotherapy.
    Li H; Wang H; Shao S; Gu Y; Yao J; Huang J
    Onco Targets Ther; 2020; 13():13121-13130. PubMed ID: 33380802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of pre-resection albumin/fibrinogen ratio in patients with non-small cell lung cancer: A propensity score matching analysis.
    Chen S; Yan H; Du J; Li J; Shen B; Ying H; Zhang Y; Chen S
    Clin Chim Acta; 2018 Jul; 482():203-208. PubMed ID: 29653085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment Albumin-to-Fibrinogen Ratio is a Promising Biomarker for Predicting Postoperative Clinical Outcomes in Patients with Colorectal Cancer.
    Xie H; Yuan G; Liu M; Huang S; Wei L; Tang S; Gan J
    Nutr Cancer; 2022; 74(8):2896-2909. PubMed ID: 35193433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albumin-to-fibrinogen ratio is an independent predictor of corticosteroid response and prognosis in patients with IgA nephropathy.
    Zhang Y; Man L
    Eur J Med Res; 2023 Apr; 28(1):146. PubMed ID: 37013663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of preoperative albumin-to-fibrinogen ratio (AFR) in patients with bladder cancer treated with radical cystectomy.
    Claps F; Rai S; Mir MC; van Rhijn BWG; Mazzon G; Davis LE; Valadon CL; Silvestri T; Rizzo M; Ankem M; Liguori G; Celia A; Trombetta C; Pavan N
    Urol Oncol; 2021 Dec; 39(12):835.e9-835.e17. PubMed ID: 34049782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of the albumin-to-fibrinogen ratio (AFR) in IgA nephropathy patients.
    Qin A; Wang S; Dong L; Jiang Z; Yang D; Tan J; Tang Y; Qin W
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109324. PubMed ID: 36244218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Preoperative Albumin-to-Fibrinogen Ratio in Patients with Bladder Cancer.
    Li S; Zhang D; Zeng S; Wu T; Wang Y; Zhang H; Wang B; Hu X
    J Cancer; 2021; 12(19):5864-5873. PubMed ID: 34475999
    [No Abstract]   [Full Text] [Related]  

  • 15. Albumin-to-Fibrinogen Ratio Independently Predicts 28-Day Mortality in Patients with Peritonitis-Induced Sepsis.
    Tai H; Zhu Z; Mei H; Sun W; Zhang W
    Mediators Inflamm; 2020; 2020():7280708. PubMed ID: 32454793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combination of preoperative fibrinogen-to-albumin ratio and postoperative TNM stage (FAR-TNM) predicts the survival in gastric cancer patients after gastrectomy.
    Zhang X; Qiu X; Yin H; Zhao W; Song L; Zhang X; Yang L; Tao M
    Biomarkers; 2023 Dec; 28(8):714-721. PubMed ID: 38059615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The value of spleen density in predicting prognosis of patients with gastric cancer after curative gastrectomy].
    Li S; Ma PF; Zhang JL; Cao YH; Liu CY; Zhang XJ; Li ZY; Xue YW; Zhao YZ
    Zhonghua Yi Xue Za Zhi; 2021 Sep; 101(34):2703-2709. PubMed ID: 34510877
    [No Abstract]   [Full Text] [Related]  

  • 18. The predictive value of the preoperative albumin-to-fibrinogen ratio for postoperative hospital length of stay in liver cancer patients.
    Li F; Ren Y; Fan J; Zhou J
    Cancer Med; 2023 Oct; 12(20):20321-20331. PubMed ID: 37815011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Values of the Prealbumin-to-Fibrinogen, Albumin-to-Fibrinogen, and Monocyte-to-Lymphocyte Ratios in Gastric Cancer.
    Zhang L; Qin S; Chen H; Hu Z; Li S
    Ann Clin Lab Sci; 2021 May; 51(3):385-392. PubMed ID: 34162569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predictive value of the preoperative C-reactive protein-albumin ratio for early recurrence and chemotherapy benefit in patients with gastric cancer after radical gastrectomy: using randomized phase III trial data.
    Xu BB; Lu J; Zheng ZF; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng CH; Huang CM; Li P
    Gastric Cancer; 2019 Sep; 22(5):1016-1028. PubMed ID: 30739259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.